1. Home
  2. ONCY vs GNSS Comparison

ONCY vs GNSS Comparison

Compare ONCY & GNSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONCY
  • GNSS
  • Stock Information
  • Founded
  • ONCY 1998
  • GNSS 1992
  • Country
  • ONCY Canada
  • GNSS United States
  • Employees
  • ONCY N/A
  • GNSS N/A
  • Industry
  • ONCY Pharmaceuticals and Biotechnology
  • GNSS Consumer Electronics/Appliances
  • Sector
  • ONCY Health Care
  • GNSS Consumer Staples
  • Exchange
  • ONCY Nasdaq
  • GNSS Nasdaq
  • Market Cap
  • ONCY 89.7M
  • GNSS 94.8M
  • IPO Year
  • ONCY 1999
  • GNSS N/A
  • Fundamental
  • Price
  • ONCY $1.36
  • GNSS $2.50
  • Analyst Decision
  • ONCY Strong Buy
  • GNSS Strong Buy
  • Analyst Count
  • ONCY 5
  • GNSS 3
  • Target Price
  • ONCY $5.00
  • GNSS $5.33
  • AVG Volume (30 Days)
  • ONCY 1.3M
  • GNSS 141.3K
  • Earning Date
  • ONCY 11-11-2025
  • GNSS 08-14-2025
  • Dividend Yield
  • ONCY N/A
  • GNSS N/A
  • EPS Growth
  • ONCY N/A
  • GNSS N/A
  • EPS
  • ONCY N/A
  • GNSS N/A
  • Revenue
  • ONCY N/A
  • GNSS $30,470,000.00
  • Revenue This Year
  • ONCY N/A
  • GNSS $90.97
  • Revenue Next Year
  • ONCY N/A
  • GNSS $75.75
  • P/E Ratio
  • ONCY N/A
  • GNSS N/A
  • Revenue Growth
  • ONCY N/A
  • GNSS 8.95
  • 52 Week Low
  • ONCY $0.33
  • GNSS $1.46
  • 52 Week High
  • ONCY $1.53
  • GNSS $4.04
  • Technical
  • Relative Strength Index (RSI)
  • ONCY 64.50
  • GNSS 79.62
  • Support Level
  • ONCY $1.20
  • GNSS $2.08
  • Resistance Level
  • ONCY $1.44
  • GNSS $2.17
  • Average True Range (ATR)
  • ONCY 0.11
  • GNSS 0.13
  • MACD
  • ONCY 0.01
  • GNSS 0.05
  • Stochastic Oscillator
  • ONCY 81.40
  • GNSS 76.74

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

About GNSS Genasys Inc.

Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.

Share on Social Networks: